Urothelial Cancer Drugs Markets and Competitive Landscape Analysis, 2024-2030, Featuring Profiles of 42 Major Companies, Including AstraZeneca, Bristol-Myers Squibb, Celgene Corporation, and Eli Lilly & Co
18 déc. 2024 05h49 HE
|
Research and Markets
Dublin, Dec. 18, 2024 (GLOBE NEWSWIRE) -- The "Urothelial Cancer Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Head and Neck Cancer Therapeutics Market Research Report 2024-2030: Technological Integration of AI and Precision Medicine in Cancer Therapeutics Enhances Growth
03 déc. 2024 05h53 HE
|
Research and Markets
Dublin, Dec. 03, 2024 (GLOBE NEWSWIRE) -- The "Head and Neck Cancer Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
India Liver Cancer Therapeutics Research Report 2024-2030 Featuring Natco Pharma, Dr. Reddy's Laboratories, Intas Pharmaceuticals, Mylan Pharmaceuticals, Lupin, Biocon, and Hetero Labs
11 sept. 2024 11h54 HE
|
Research and Markets
Dublin, Sept. 11, 2024 (GLOBE NEWSWIRE) -- The "India Liver Cancer Therapeutics Market, By Region, Competition, Forecast & Opportunities, 2020-2030F" report has been added to ...
Advanced Liver Cancer Therapeutics Research 2024: Comprehensive Insights About 50+ Companies and 50+ Pipeline Drugs - Product Type, Stage, Route of Administration, and Molecule Type
01 juil. 2024 07h54 HE
|
Research and Markets
Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Advanced liver cancer - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Advanced liver cancer -...
Global Immune Checkpoint Inhibitors Market Analysis Report 2024-2030: Growing FDA Approvals of Immune Checkpoint Inhibitors and Increasing Funding for Advancing Cancer Immunotherapy
24 juin 2024 10h26 HE
|
Research and Markets
Dublin, June 24, 2024 (GLOBE NEWSWIRE) -- The "Global Immune Checkpoint Inhibitors Market Size, Share & Trends Analysis Report by Type (PD-1, PD-L1, CTLA-4), Application (Lung Cancer, Breast...
Global KRAS Inhibitors Market & Clinical Trials Future Market Outlook 2030: 2 Approved KRAS Inhibitors and 90+ Drugs KRAS Inhibitors in Clinical Trials
20 juin 2024 06h59 HE
|
Research and Markets
Dublin, June 20, 2024 (GLOBE NEWSWIRE) -- The "Global KRAS Inhibitors Market & Clinical Trials Future Outlook 2030" report has been added to ResearchAndMarkets.com's offering. With the...
Oncolytic Virus Cancer Therapy Pipeline Analysis, 2024 - Showing Promise with Over 120 Companies and 125 Drugs in Development
14 juin 2024 06h51 HE
|
Research and Markets
Dublin, June 14, 2024 (GLOBE NEWSWIRE) -- The "Oncolytic Virus Cancer Therapy - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.The field of oncolytic virus...
Global Tetraspecific Antibodies Clinical Trials & Market Report 2024: Pioneering the Future of Cancer Treatment, Shift Towards Tetraspecific Antibodies Amidst Drug Resistance Challenges
31 mai 2024 04h48 HE
|
Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Global Tetraspecific Antibodies Clinical Trials & Market Opportunity Insight 2024" report has been added to ResearchAndMarkets.com's...
Immune Checkpoint Drugs in Oncology: Analytical Tool – A Must-Have Handbook for Business Developers, BI/CI Operatives, and Clinical Developers
25 avr. 2024 10h26 HE
|
Research and Markets
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Immune-checkpoint Drugs in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com's offering.Cancer cells sometimes find ways to...
PD-1 and PD-L1 Inhibitors Competitive Landscape Report 2024: Clinical Assessment of Over 200 Drugs Being Developed by More than 180 Companies
01 mars 2024 08h58 HE
|
Research and Markets
Dublin, March 01, 2024 (GLOBE NEWSWIRE) -- The "PD-1 and PD-L1 Inhibitors - Competitive Landscape, 2024" report has been added to ResearchAndMarkets.com's offering.This "PD-1 and PD-L1 Inhibitors -...